Showing results (51-60 of 201) with videos related to
Sort By:
Pageof 21
Blood|June 1, 1993
Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factorW Bensinger, J Singer, F Appelbaum, et al.Bone Marrow Transplantation|July 1, 1989
Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remissionW Bensinger, F B Petersen, M Banaji, et al.Bone Marrow Transplantation|April 25, 2006
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationK Lilleby, P Garcia, T Gooley, et al.Bone Marrow Transplantation|July 15, 2003
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimenF Gutierrez-Delgado, L Holmberg, H Hooper, et al.Experimental Hematology|May 1, 1985
Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remissionP Stewart, C D Buckner, W Bensinger, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow TransplantationJ H Antin, R Childs, A H Filipovich, et al.Leukemia|March 1, 1997
Studies of decitabine with allogeneic progenitor cell transplantationS Giralt, M Davis, S O'Brien, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignanciesC Ippoliti, R Champlin, N Bugazia, et al.Blood|February 1, 1988
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trialsR Storb, H J Deeg, L Fisher, et al.The New England Journal of Medicine|March 20, 1986
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaR Storb, H J Deeg, J Whitehead, et al.Pageof 21